Itay Weinstein - XTL Biopharmaceutica Chief Officer
| XTLB Stock | ILS 6.70 0.20 3.08% |
Insider
Itay Weinstein is Chief Officer of XTL Biopharmaceuticals
| Age | 52 |
| Phone | 972 3 611 6600 |
| Web | https://www.xtlbio.com |
XTL Biopharmaceutica Management Efficiency
The company has return on total asset (ROA) of (0.1001) % which means that it has lost $0.1001 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3822 %, meaning that it generated $0.3822 on every $100 dollars invested by stockholders. XTL Biopharmaceutica's management efficiency ratios could be used to measure how well XTL Biopharmaceutica manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Itay Rafael | Ratio Oil Explorations | 44 | |
| Shiri Neder | Nice | 47 | |
| Eyal BenHaim | Bank Leumi Le Israel | 52 | |
| Shmulik Arbel | Bank Leumi Le Israel | 54 | |
| Assaf Ginzburg | Ormat Technologies | 48 | |
| Nitzan Moshe | ICL Israel Chemicals | 52 | |
| Ziv CPA | Bank Leumi Le Israel | 52 | |
| Moshe MBA | Mizrahi Tefahot | 52 | |
| Adi Kaplan | Israel Discount Bank | 50 | |
| Josh Steinberg | Ratio Oil Explorations | N/A | |
| Liza Tavori | Ormat Technologies | N/A | |
| Yigal Landau | Ratio Oil Explorations | 63 | |
| Barak Nardi | Israel Discount Bank | 49 | |
| Assaf Eldar | Israel Discount Bank | 48 | |
| Anantha Desikan | ICL Israel Chemicals | 51 | |
| Lena Schwartz | Israel Discount Bank | N/A | |
| Eyal Henkin | Azrieli Group | 54 | |
| Moran Goder | Azrieli Group | N/A | |
| Noam Goldstein | ICL Israel Chemicals | 62 | |
| Noa Burla | Ratio Oil Explorations | 42 | |
| Gil Rogozinski | Ratio Oil Explorations | 53 | |
Management Performance
| Return On Equity | 0.38 | |||
| Return On Asset | -0.1 |
XTL Biopharmaceuticals Management Team
Elected by the shareholders, the XTL Biopharmaceutica's board of directors comprises two types of representatives: XTL Biopharmaceutica inside directors who are chosen from within the company, and outside directors, selected externally and held independent of XTL. The board's role is to monitor XTL Biopharmaceutica's management team and ensure that shareholders' interests are well served. XTL Biopharmaceutica's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, XTL Biopharmaceutica's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Itay Weinstein, Chief Officer | ||
| Shlomo Shalev, CEO Director | ||
| Ronen Kantor, Company Sec |
XTL Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is XTL Biopharmaceutica a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.38 | |||
| Return On Asset | -0.1 | |||
| Current Valuation | 61.84 M | |||
| Shares Outstanding | 514.21 M | |||
| Shares Owned By Insiders | 16.20 % | |||
| Price To Earning | 558.33 X | |||
| EBITDA | (940 K) | |||
| Net Income | 435 K | |||
| Cash And Equivalents | 5.06 M | |||
| Cash Per Share | 0.01 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in XTL Stock
XTL Biopharmaceutica financial ratios help investors to determine whether XTL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XTL with respect to the benefits of owning XTL Biopharmaceutica security.